Blood cancers, Chronic leukaemia, Leukaemia
Results
Phase 2
This trial was done to see if azacitidine is a safe and helpful treatment for chronic myelomonocytic leukaemia (CMML). This trial was supported by Cancer Research UK.
Recruitment start: 18 January 2010
Recruitment end: 17 August 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Bowen
Cancer Research UK
Celgene Ltd
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
The Leeds Teaching Hospitals NHS Trust
This is Cancer Research UK trial number CRUK/08/034.
Last reviewed: 13 August 2014
CRUK internal database number: 3353
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
